Youtube - All Videos

This Stream includes all Videos from PAREXELInternational's YouTube Account

  • Unlocking the China Potential  -  Shamim Chowdhury1:50

    Unlocking the China Potential - Shamim Chowdhury

    Watch Video
  • Agency Readiness – Bob Iser2:47

    Agency Readiness – Bob Iser

    Watch Video
  • Accelerated Pathways – Alberto Grignolo2:53

    Accelerated Pathways – Alberto Grignolo

    Watch Video
  • #DIA2018 | Alberto Grignolo on Expedited Pathways0:53

    #DIA2018 | Alberto Grignolo on Expedited Pathways

    From the floor at #DIA2018 - PAREXEL Corporate VP Alberto Grignolo shares his views on the proliferation of expedited regulatory approval pathways in key markets and its implications for global clinic

    Watch Video
  • Michelle Hoiseth on the Importance of Real-World Data1:49

    Michelle Hoiseth on the Importance of Real-World Data

    Real-World Data provides important opportunities for the drug development industry. Michelle Hoiseth, PAREXEL Corporate VP, Real-World Data Services, explores those opportunities during an interview a

    Watch Video
  • Andrew Wilson1:21
    Watch Video
  • Michelle 21:49
    Watch Video
  • #DIA2018 | David Humphreys on the EIU research commissioned by PAREXEL1:35

    #DIA2018 | David Humphreys on the EIU research commissioned by PAREXEL

    From the floor at #DIA2018 - David Humphreys, Global Head of Health Policy for the Economist Intelligence Unit, discusses 'The Innovation Imperative: The Future of Drug Development' - a first-of-its-k

    Watch Video
  • Patient Centric Approaches and Precision Medicine in Clinical Trials47:05

    Patient Centric Approaches and Precision Medicine in Clinical Trials

    Listen to PAREXEL’s team from Early Phase and Genomic Medicine discuss patient centric approaches to study design and execution to overcome hurdles in patient recruitment and biobanking.

    Watch Video
  • #DIA2018 | Alberto Grignolo on the Japanese Regulatory Landscape1:44

    #DIA2018 | Alberto Grignolo on the Japanese Regulatory Landscape

    From the floor at #DIA2018 - PAREXEL Corporate VP Alberto Grignolo discusses the ongoing evolution of Japan's clinical development regulatory environment.

    Watch Video
  • #DIA2018 | Alberto Grignolo on 4 Key Innovations3:04

    #DIA2018 | Alberto Grignolo on 4 Key Innovations

    From the floor at #DIA2018 - PAREXEL Corporate VP Alberto Grignolo details the innovations referenced in the EIU report and how they are influencing discussion at the DIA Annual Meeting.

    Watch Video
  • #DIA2018 | Alberto Grignolo on Expedited Pathways0:51

    #DIA2018 | Alberto Grignolo on Expedited Pathways

    From the floor at #DIA2018 - PAREXEL Corporate VP Alberto Grignolo shares his views on the proliferation of expedited regulatory approval pathways in key markets and its implications for global clinic

    Watch Video
  • #DIA2018 | Michelle Hoiseth on Real-World Data in Drug Development1:50

    #DIA2018 | Michelle Hoiseth on Real-World Data in Drug Development

    From the floor at #DIA2018 - PAREXEL Corporate VP Michelle Hoiseth discusses the importance of Real-Word Data to the future of drug development and how discussions on the topic are moving from theory

    Watch Video
  • #DIA2018 | Alberto Grignolo on Key Enablers for Innovation in Drug Development2:56

    #DIA2018 | Alberto Grignolo on Key Enablers for Innovation in Drug Development

    From the floor at #DIA2018 - PAREXEL Corporate VP Alberto Grignolo shares the enablers to innovation described in the EIU report and the corresponding call to action beyond the DIA Annual Meeting.

    Watch Video
  • #DIA2018 | Alberto Grignolo on Key Enablers for Innovation in Drug Development3:39

    #DIA2018 | Alberto Grignolo on Key Enablers for Innovation in Drug Development

    From the floor at #DIA2018 - PAREXEL Corporate VP Alberto Grignolo shares the enablers to innovation described in the EIU report and the corresponding call to action beyond the DIA Annual Meeting.

    Watch Video
  • #DIA2018 | Alberto Grignolo on the EIU findings1:36

    #DIA2018 | Alberto Grignolo on the EIU findings

    From the floor at #DIA2018 - PAREXEL Corporate VP, Alberto Grignolo, on his presentation of the EIU findings.

    Watch Video
  • #DIA2018 | Microsoft's Desmond Creary on how Savings from Innovation Can Fuel R&D1:08

    #DIA2018 | Microsoft's Desmond Creary on how Savings from Innovation Can Fuel R&D

    From the floor at #DIA2018 - Microsoft Health Leader Desmond Creary explores how savings from innovation can help fuel greater R&D investment.

    Watch Video
  • #DIA2018 | Sy Pretorius on the Economist Intelligence Unit Findings1:48

    #DIA2018 | Sy Pretorius on the Economist Intelligence Unit Findings

    From the floor at #DIA2018 - PAREXEL Chief Scientific Officer Sy Pretorius shares his take on adaptive trials and other key findings from the Economist Intelligence Unit report.

    Watch Video
  • #DIA2018 | Xavier Flinois on Technical Innovations & PAREXEL's Alliance with MSFT2:03

    #DIA2018 | Xavier Flinois on Technical Innovations & PAREXEL's Alliance with MSFT

    From the floor at #DIA2018 - PAREXEL Informatics President Xavier Flinois shares his thoughts on utilizing technology in clinical research more effectively as well as our alliance with Microsoft.

    Watch Video
  • #DIA2018 | Microsoft's Desmond Creary on the PAREXEL Alliance1:32

    #DIA2018 | Microsoft's Desmond Creary on the PAREXEL Alliance

    From the floor at #DIA2018 - Microsoft Health Leader Desmond Creary shares his perspective on how PAREXEL's alliance with Microsoft can help to move the drug development industry forward.

    Watch Video
  • loading
    Loading More...